Logos Global Management »

Onkure Therapeutics Inc-a shares owned by Logos Global Management

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Logos Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.4M 964k 4.56

More positions owned by Logos Global Management

Erasca (ERAS)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Ideaya Biosciences (IDYA)
Biontech Se Sponsored Ads (BNTX)
Vera Therapeutics Cl A (VERA)
Tango Therapeutics (TNGX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Dianthus Therapeutics (DNTH)
Cg Oncology (CGON)
Disc Medicine (IRON)
Maze Therapeatics (MAZE)
Dyne Therapeutics (DYN)
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Logos Global Management

Top funds holding Onkure Therapeutics Inc-a

RA Capital Management
BVF
Acorn Capital Advisors
StepStone
ADAR1 Capital Management
Vivo Capital
Vestal Point Capital
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Adage Capital Partners GP
Citadel Advisors
Sio Capital Management
Prosight Management
Logos Global Management

View all funds holding Onkure Therapeutics Inc-a